Peter K. Marschel - hubXchange

Loading

Peter K. Marschel - Decoy Therapeutics

Peter K. Marschel

Co-Founder and Chief Business Officer, Decoy Therapeutics

Sessions

30-Apr-2026

15:45 – 16:45
What are the key challenges in transitioning from natural ligand reengineering to de novo computational design of peptide therapeutics